Establishment Labs Shares up 13.9% After Co Receives U.S. FDA Approval for Motiva Implants
收到美國FDA批准Motiva植入物後,establishment labs股價上漲13.9%
Establishment Labs Shares up 13.9% After Co Receives U.S. FDA Approval for Motiva Implants
收到美國FDA批准Motiva植入物後,establishment labs股價上漲13.9%
譯文內容由第三人軟體翻譯。
使用瀏覽器的分享功能,分享給你的好友吧